Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

MSVOX

MSIF Vitality Portfolio Class R6

MSVOX Mutual Fund Price & Analysis

MSIF Vitality Portfolio Class R6 (MSVOX) is a mutual fund that focuses on investing in a diverse range of assets, including stocks, bonds, and other securities. It is designed to provide long-term growth and capital appreciation for investors. The fund is managed by Morgan Stanley Investment Management and has a low expense ratio, making it an attractive option for investors looking for a cost-effective way to diversify their portfolio. With a focus on vitality and sustainability, this fund aims to provide a balanced and stable investment option for its shareholders.

MSVOX Mutual Fund Chart & Stats

MSVOX Mutual Fund News

PremiumThe Fly

Eli Lilly announces FDA approval for Zepbound for obstructive sleep apnea

2d ago

LLY

PremiumThe Fly

Eli Lilly announces FDA approval for Zepbound

2d ago

LLY

PremiumCompany Announcements

Vertex Pharmaceuticals Gains FDA Approval for Cystic Fibrosis Drug

2d ago

VRTX

PremiumThe Fly

Vertex announces FDA approval of Alyftrek

2d ago

VRTX

MSVOX Mutual Fund Smart Score

Neutral

Analyst Consensus

Strong Buy

Average Price Target:
$8.96 (― Downside)

Learn more about TipRanks Smart Score

For Mutual Funds, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the Mutual Fund's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual Mutual Fund ticker.